EXPERIMENTAL DRUG DEVELOPMENT CENTRELegal Entity
EXPERIMENTAL DRUG DEVELOPMENT CENTRE is ACRA -registered entity that has been operating for 17 years 11 months in Singapore since its incorporation in 2007.
Officially, EXPERIMENTAL DRUG DEVELOPMENT CENTRE is registered as undefined with its address 20 BIOPOLIS WAY, #07-01, CENTROS, Singapore 138668.
EXPERIMENTAL DRUG DEVELOPMENT CENTRE is a non-listed entity in the private market with no IPO filing
As of 1 March 2020, the company is not involved in any litigation based on the public records of the Supreme Court of Singapore. This information is provided to the best of our research ability and we make no warranties over any data inaccuracies or omissions
Associated business (12)
To find out more insights such as size, news, key decision makers, please visit the profile pages below.
- The A*STAR’s Singapore Institute of Manufacturing Technology (SIMTech) and the Advanced Remanufacturing Technology Centre (ARTC) offer unparalleled technology training and real-world case study-based instruction to bolster the competitiveness and abilities of our workforce in the dynamic manufacturing industry of Singapore. Our training programmes, in close partnership with the SkillsFuture Singapore (SSG) Agency and other leading organisations, are built on the foundation of our extensive in-house expertise in cutting-edge manufacturing knowledge, gained through years of industry collaborations, hands-on experience, and research. Equipped with state-of-the-art manufacturing facilities, our innovative Learn-Practice-Implement™ (LPI™) model has earned a reputation as an effective approach for upskilling and reskilling the workforce.\n\nThe Knowledge Transfer Office (KTO), an entity spanning both SIMTech and ARTC, is at the forefront of workforce training in advanced manufacturing. With a holistic approach that leverages the expertise and resources of both institutes, the KTO is dedicated to delivering comprehensive and impactful training programmes that empower the workforce and drive the competitiveness of Singapore's manufacturing industry.\n\nWith the goal of ensuring that our workers have the necessary skills to thrive in the industry, our training programmes are designed to meet the evolving needs of the market and provide a comprehensive learning experience that is both practical and impactful.
- Founded in 2007, the Singapore Institute for Clinical Sciences (SICS) aims to improve health and human capacity through clinical research and translational science. Our mission is to investigate the complex interplay between physiological makeup and environmental factors to develop innovative solutions for better health outcomes. We have launched groundbreaking nationwide studies such as GUSTO and S-PRESTO to advance scientific knowledge and create a brighter future for generations to come.
- At Bioprocessing Technology Institute (BTI), we specialize in bioprocess science and engineering to support industries locally and globally. With integrated capabilities under one roof, we address challenges from end to end along the biomanufacturing value chain, developing bioprocesses for manufacturing recombinant proteins, antibodies, vaccines, viruses, cell/gene therapies, engineered tissues, and alternative proteins for over 30 years. Contact us at [email protected].
- A*STAR GRADUATE ACADEMYSingaporeAt A*STAR Graduate Academy (A*GA), our mission is to cultivate and develop the next generation of talented scientists and researchers to support Singapore's aspiration of becoming a world-class scientific hub. We offer comprehensive scholarships and fellowships for undergraduate, Ph.D., and post-doctoral studies, both locally and abroad, to identify and nurture young talent. Our outreach programs also aim to foster a diverse and vibrant community of young scientific minds in Singapore. Through these initiatives, we strive to enhance A*STAR's human capital development and provide a unique, interdisciplinary, and globally connected environment that encourages creativity, innovation, and diversity in our R&D efforts.
- A*STAR Infectious Diseases (ID) Labs is a leading center of infectious diseases research excellence in antimicrobial resistance, respiratory and vector-borne diseases. Our mission is to contribute to Singapore's national preparedness and defense against emerging infections through cutting-edge translational research, leveraging strong local and international partnerships, and training future leaders in infectious diseases research.
- The A*STAR Infectious Diseases (ID) Labs was established in 2021 to consolidate multi-disciplinary capabilities around infectious diseases research, with a focus on enhancing preparedness and filling gaps learned from COVID-19. Led by Professor Lisa Ng, the ID Labs aim to be a leading institution in this field.
- The Agency for Science, Technology and Research (A*STAR) is a leading public sector agency in Singapore that drives economic oriented research to advance scientific discovery and develop innovative technologies. We collaborate with partners from both the public and private sectors to benefit society through open innovation. Our research creates economic growth and jobs, and contributes to societal benefits such as improved healthcare, sustainable urban living, and enhanced quality of life. We nurture and develop diverse talent and leaders in our agency and research entities, and our R&D activities span biomedical sciences and physical sciences and engineering, with research entities primarily located in Biopolis and Fusionopolis.
- A*STAR FUSIONWORLDSingaporeFusionWorld is a platform for showcasing technologies and innovations developed by the Agency for Science, Technology and Research (A*STAR). Our mission is to connect companies with A*STAR's research capabilities and help them leverage these technologies to create new products, services, and markets that make a positive impact on people's lives. Through interactive exhibits and immersive experiences, we provide visitors with a comprehensive overview of A*STAR's research areas and first-hand insights into our cutting-edge technologies.
- A*STAR's Institute of Bioengineering and Bioimaging (IBB) conducts interdisciplinary research at the intersection of biology, chemistry, engineering, artificial intelligence, and medicine. The institute focuses on three key areas: Biomedical Devices & Diagnostics, Bioengineering Systems, and Biophotonics & Bioimaging. IBB collaborates with various partners to develop innovative solutions in strategic areas such as cancer, infectious diseases, and food and nutrition. With a team of 130 experts and state-of-the-art equipment, IBB has established over 10 spin-off companies and published numerous high-impact papers. For inquiries regarding staff and student positions or collaborations, please contact us at [email protected].
- A*STAR INSTITUTE OF MEDICAL BIOLOGYSingapore
- The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector agency dedicated to advancing scientific discovery and developing innovative technologies through open innovation. We collaborate with partners in both the public and private sectors to benefit society, creating economic growth and jobs, and enhancing lives through research in areas such as healthcare, urban living, and sustainability. By nurturing and developing diverse talent and leaders, we contribute to the wider research community and industry, with research entities primarily located in Biopolis and Fusionopolis.
- At The Genome Institute of Singapore (GIS), our mission is to harness the power of genomic sciences to drive extraordinary improvements in human health and public prosperity. As a trusted producer, custodian, and curator of Singapore's genomic data, we leverage our core capabilities in high-quality sequencing and large-scale genome informatics to deliver impactful solutions for A*STAR, Singapore, and the global community.
Country of registration | Singapore |
Registration number | 53090262A |
Local SIC | |
Incorporation date | 13 Apr 2007 |
Company age | 17 years 11 months |
No. of officers | 2 |
Financials
Revenue | 1 - 10m |
Lookalike companies
Frequently Asked Questions (FAQ)
- Tell me more about EXPERIMENTAL DRUG DEVELOPMENT CENTRE?
EXPERIMENTAL DRUG DEVELOPMENT CENTRE is ACRA -registered entity that has been operating for 17 years 11 months in Singapore since its incorporation in 2007.
Officially, EXPERIMENTAL DRUG DEVELOPMENT CENTRE is registered as undefined with its address 20 BIOPOLIS WAY, #07-01, CENTROS, Singapore 138668.
EXPERIMENTAL DRUG DEVELOPMENT CENTRE is a non-listed entity in the private market with no IPO filing
As of 1 March 2020, the company is not involved in any litigation based on the public records of the Supreme Court of Singapore. This information is provided to the best of our research ability and we make no warranties over any data inaccuracies or omissions
- What is EXPERIMENTAL DRUG DEVELOPMENT CENTRE's incorporation date?EXPERIMENTAL DRUG DEVELOPMENT CENTRE was incorporated on 13 Apr 2007
- What sector is EXPERIMENTAL DRUG DEVELOPMENT CENTRE in?EXPERIMENTAL DRUG DEVELOPMENT CENTRE primarily operates in the sector of Research and experimental development on environment and clean technologies
- What is the business registration number of EXPERIMENTAL DRUG DEVELOPMENT CENTRE?The business registration number of EXPERIMENTAL DRUG DEVELOPMENT CENTRE is 53090262A
- What is the legal name?The legal name is EXPERIMENTAL DRUG DEVELOPMENT CENTRE
- What is the address of EXPERIMENTAL DRUG DEVELOPMENT CENTRE?The address of EXPERIMENTAL DRUG DEVELOPMENT CENTRE is 20 BIOPOLIS WAY, #07-01, CENTROS, Singapore 138668
- What is EXPERIMENTAL DRUG DEVELOPMENT CENTRE's ownership structure?EXPERIMENTAL DRUG DEVELOPMENT CENTRE has a [sophisticated] ownership structure and [may be part of a large corporate group]